3 Stocks Estimated To Be Trading At Discounts Of Up To 41.8%

In This Article:

As global markets experience broad-based gains and U.S. indexes approach record highs, investors are navigating a landscape marked by geopolitical tensions and economic uncertainties. Amidst these conditions, identifying undervalued stocks can be a strategic move for those looking to capitalize on potential market inefficiencies.

Top 10 Undervalued Stocks Based On Cash Flows

Name

Current Price

Fair Value (Est)

Discount (Est)

Alltop Technology (TPEX:3526)

NT$279.50

NT$555.22

49.7%

Gaming Realms (AIM:GMR)

£0.3665

£0.73

49.6%

Kehua Data (SZSE:002335)

CN¥22.98

CN¥45.54

49.5%

S-Pool (TSE:2471)

¥339.00

¥676.60

49.9%

EnomotoLtd (TSE:6928)

¥1474.00

¥2936.95

49.8%

Equity Bancshares (NYSE:EQBK)

US$49.21

US$98.42

50%

Intermedical Care and Lab Hospital (SET:IMH)

THB4.94

THB9.85

49.8%

Fine Foods & Pharmaceuticals N.T.M (BIT:FF)

€7.88

€15.63

49.6%

Shanghai INT Medical Instruments (SEHK:1501)

HK$27.45

HK$54.36

49.5%

ASMPT (SEHK:522)

HK$73.00

HK$145.81

49.9%

Click here to see the full list of 923 stocks from our Undervalued Stocks Based On Cash Flows screener.

Let's review some notable picks from our screened stocks.

Ryman Healthcare

Overview: Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for elderly people in New Zealand and Australia with a market cap of NZ$3.47 billion.

Operations: The company's revenue is primarily derived from the provision of integrated retirement villages for older people, amounting to NZ$687.56 million.

Estimated Discount To Fair Value: 41.8%

Ryman Healthcare is trading at NZ$5.07, significantly below its estimated fair value of NZ$8.72, making it undervalued based on discounted cash flow analysis. Despite high debt levels and recent profit margin declines to 0.7%, earnings are expected to grow significantly at 26.75% annually over the next three years, outpacing the New Zealand market's average growth rate of 24.7%. Analysts anticipate a price increase by 23.4%, reflecting positive sentiment towards future performance.

NZSE:RYM Discounted Cash Flow as at Nov 2024
NZSE:RYM Discounted Cash Flow as at Nov 2024

ZJLD Group

Overview: ZJLD Group Inc is involved in the production and sale of baijiu products in China, with a market cap of HK$22.23 billion.

Operations: The company's revenue primarily comes from its baijiu product lines, with CN¥4.98 billion from Zhen Jiu, CN¥1.29 billion from Li Du, CN¥844.13 million from Xiang Jiao, and CN¥388.16 million from Kai Kou Xiao.